tiprankstipranks
Rigel (RIGL)
NASDAQ:RIGL
US Market
RIGL
Rigel
RESEARCH TOOLSreports
Want to see RIGL full AI Analyst Report?

Rigel (RIGL) Stock News & Sentiment

1,604 Followers
Rigel Secures Global Rights to VEPPANU Breast Cancer Therapy
Premium
Company Announcements
Rigel Secures Global Rights to VEPPANU Breast Cancer Therapy
6d ago
8K
RIGL
Analyst Reiterates Buy on Rigel as VEPPANU Acquisition Expands Portfolio; Price Target Maintained at $57
Premium
Ratings
Analyst Reiterates Buy on Rigel as VEPPANU Acquisition Expands Portfolio; Price Target Maintained at $57
6d ago
RIGL
Rigel Pharmaceuticals Signals Profitable Growth After Earnings Call
Premium
Company Announcements
Rigel Pharmaceuticals Signals Profitable Growth After Earnings Call
12d ago
RIGL
Is RIGL a Buy, Before Earnings?
Premium
Pre-Earnings
Is RIGL a Buy, Before Earnings?
16d ago
RIGL
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating
Premium
Ratings
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating
27d ago
RIGL
Rigel Regains Rights as Eli Lilly Ends Collaboration
Premium
Company Announcements
Rigel Regains Rights as Eli Lilly Ends Collaboration
27d ago
8K
RIGL
Rigel Pharmaceuticals Balances Breakout Growth With Caution
Premium
Company Announcements
Rigel Pharmaceuticals Balances Breakout Growth With Caution
2M ago
RIGL
More RIGL News >

RIGL News on the Web

Rigel Pharmaceuticals Balances Breakout Growth With Caution
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Palisade Bio (PALI), Rigel (RIGL)
TipRanks News
Bullish
Rigel Pharmaceuticals’ pralsetinib shows efficacy in NSCLC clinical trial
TipRanks News
Bullish
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Zacks
Neutral
Rigel’s New Olutasidenib Interaction Study Signals Long-Game Strategy for RIGL Investors
TipRanks News
Bullish
Rigel Pharmaceuticals’ Fast Track Ambitions Face Significant FDA Uncertainty
TipRanks News
Neutral
Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026
GuruFocus News
Bearish
Cantor Fitzgerald Remains a Hold on Rigel (RIGL)
TipRanks News
Neutral

News Score - Last 7 Days

Positive
RIGL
Sector Average
Media Buzz
This Week4 articles
Weekly Average5 articles
News Sentiment
This Week67%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RIGL’s Media Buzz Sentiment?
4 articles about RIGL were published this week. In an average week, 5 articles are published.
    What is RIGL’s weekly average amount of articles?
    In an average week, 5 articles about RIGL are published.
      What is RIGL’s News Sentiment?
      67% of articles about RIGL were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week